Vincent S LoPriore Insider Profile
11 Followers
Vincent S LoPriore, EC, Director at Hepion Pharmaceuticals, holds 30.50M shares in Hepion Pharmaceuticals (Ticker: HEPA), holds ― shares in Canton Strategic Holdings (Ticker: CNTN). Most recently, Vincent S LoPriore Bought ― shares of Hepion Pharmaceuticals on Aug 12, 2026 for an estimated value of $400.00K.
Vincent S LoPriore's Trading History
You May Also Like
Vincent S LoPriore insider profile FAQ
What is the percentage of profitable transactions made by Vincent S LoPriore?
The percentage of profitable transactions made by Vincent S LoPriore is 100%.
What is the average return per transaction made by Vincent S LoPriore?
The average return per transaction made by Vincent S LoPriore is 103.60%.
What stocks does Vincent S LoPriore hold?
Vincent S LoPriore holds: HEPA, CNTN stocks.
What was Vincent S LoPriore’s latest transaction?
Vincent S LoPriore’s latest transaction was an Informative Buy of $400.00K.
What was Vincent S LoPriore's most profitable transaction?
Vincent S LoPriore’s most profitable transaction was an Informative Buy of HEPA stock on August 12, 2026. The return on the trade was 123.50%.
What is Vincent S LoPriore's role in Hepion Pharmaceuticals?
Vincent S LoPriore's role in Hepion Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.